What increasing hope for Biogen Alzheimer’s drug means for Eli Lilly

Wall Street increasingly believes U.S. drug regulators will approve Biogen ‘s (BIIB) latest experimental Alzheimer’s treatment following the release of detailed late-stage clinical trial data. It’s a development that may carry positive implications for Eli Lilly (LLY) because the Club holding is investigating a similar drug targeting the disease. Lecanemab — jointly developed by Biogen … Read more

Jim Cramer says these 10 ‘old guard’ stocks are making a comeback

CNBC’s Jim Cramer on Tuesday offered investors a list of 10 companies that he believes are rising to the top as tech stocks collapse. “It’s the revenge of the old guard right now, right here. All sorts of boring, conventional companies are taking back the market while the digitizers and disruptors are being burned,” he … Read more

Meta is no longer one of the 20 biggest U.S. companies

Mark Zuckerberg during Metaverse conversation on CNBC Source: CNBC Sixteen months after Facebook crossed $1 trillion in market cap, joining an exclusive club consisting of Apple, Microsoft, Apple and Amazon, its parent company Meta is worth less than Home Depot and barely more than Pfizer and Coca-Cola. Far from Facebook’s Big Tech days, Meta is … Read more

Omicron subvariants show resistance, putting some people at risk

Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter, the White House warned this week. “With some of the new subvariants that are emerging, some of the main tools we’ve had to protect the immunocompromised like Evusheld … Read more

This bear market is getting long in the tooth — here’s what is changing

Something’s happening. You can feel it. The down days, as painful as they are, seem more muted. The up days show a dearth of supply. Most important: When we get through earnings, we will have plenty of companies buying back shares and, more than ever, it might matter. If there is not much “above,” meaning … Read more

What Cramer is watching Thursday — OPEC+ surprise, Corona beer maker beat, Costco's sales

OPEC+'s 2 million barrels-per-day oil production cut to boost prices. U.S. delivers an angry rebuke.

What Cramer is watching Wednesday — oversold market bounce; promising Alzheimer's drug

Our trusted S&P Oscillator at minus 12.6. That indicates extremely oversold conditions.

Amazon, Eli Lilly, Bed Bath & Beyond, Nike

Here are the biggest calls on Wall Street on Thursday: UBS upgrades Eli Lilly to buy from neutral UBS says it’s bullish on the company’s weight loss drug and sees upside potential. “With these events in the rear-view mirror, we now view LLY as being the most attractive name in our large cap coverage, with … Read more

Accenture, Darden Restaurants, home builders

Check out the companies making headlines before the bell: Accenture (ACN) – The consulting firm reported a better-than-expected quarterly profit and revenue, but gave a weaker-than-expected revenue forecast for the current quarter. Accenture pointed to IT spending cuts by corporate customers and a negative impact from the stronger dollar. Nonetheless, Accenture gained 1% in premarket … Read more